{"id":"W4213345473","doi":"10.1200/jco.2022.40.6_suppl.105","title":"Efficacy and safety of relugolix in black men with advanced prostate cancer: A subgroup analysis from the randomized, phase 3 HERO study versus leuprolide.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Subgroup analysis; Testosterone (patch); Randomized controlled trial; Internal medicine; Gynecology; Hormone antagonist; Urology; Oncology; Cancer; Hormone; Confidence interval; Endocrine system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002567722,0.001072811,0.002557867,0.0004752958,0.0002893636,0.0007898186,0.0005184151,0.0008949242,0.003356904],"category_scores_gemma":[0.002404631,0.0003744886,0.005126513,0.0004157099,0.0004154627,0.0005032075,0.0004184409,0.001345929,0.0003587623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005171512,"about_ca_system_score_gemma":0.000820604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006779174,"about_ca_topic_score_gemma":0.002583584,"domain_scores_codex":[0.9989799,0.0005885659,0.0000928299,0.0001184016,0.00009449728,0.000125702],"domain_scores_gemma":[0.9988866,0.0003519902,0.0003483488,0.0001197953,0.00007717228,0.0002161446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9549877,0.0017757,0.008877039,0.0007996008,0.01092796,0.00008992418,0.00008583129,0.0004001523,0.004148001,0.0000807196,0.0006918777,0.01713555],"study_design_scores_gemma":[0.7371452,0.1510817,0.07278138,0.0002260136,0.03160236,0.0003226224,0.0002624278,0.001766291,0.001955577,0.0005921684,0.002171977,0.00009234952],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885488,0.007585818,0.0004179334,0.0003412651,0.0001373063,0.0008808174,0.001089363,0.00003613849,0.0009624967],"genre_scores_gemma":[0.9945548,0.001669252,0.0005314897,0.0005100644,0.0001808559,0.0007282228,0.001164144,0.0000168257,0.0006443884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003356904,"threshold_uncertainty_score":0.01357961,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08102293201287776,"score_gpt":0.4851865176901473,"score_spread":0.4041635856772695,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}